The study, which looked at 1,626 cases of myocarditis, showed that the Pfizer vaccine poses the highest risk, with 105.9 cases per million doses after the second vaccine for males aged 16 to 17 and 70.7 cases per million doses after the second shot in the 12 to 15 age group.